Zobrazeno 1 - 10
of 59
pro vyhledávání: '"David G, Maloney"'
Autor:
Yi Bin Chen, Stephen J. Forman, Alex F. Herrera, Joseph H. Antin, Philippe Armand, Auayporn Nademanee, Lu Chen, David G. Maloney, Sirin Khajavian, Matthew L Chase, Vincent T. Ho, Robert J. Soiffer, Mazyar Shadman, Justin Darrah
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2383-2387
Background: Primary mediastinal large B-cell lymphoma (PMBCL) is a subset of aggressive B-cell non-Hodgkin lymphoma (B-NHL) with distinct biological and clinical features. Although most patients are cured with frontline chemoimmunotherapy with or wit
Autor:
Alexandre V. Hirayama, Damian J. Green, Terry Stevens-Ayers, Joshua A. Hill, Andrew J. Cowan, Justin J. Taylor, Joyce Maalouf, Laurel Joncas-Schronce, Carla S Walti, Jacob Keane-Candib, Elizabeth M Krantz, Jim Boonyaratanakornkit, Michael Boeckh, Rebecca Gardner, Merav Bar, Cameron J. Turtle, David G. Maloney, Sayan Dasgupta
Publikováno v:
JCI Insight
BACKGROUND Little is known about pathogen-specific humoral immunity after chimeric antigen receptor–modified T (CAR-T) cell therapy for B cell malignancies. METHODS We conducted a prospective cross-sectional study of CD19-targeted or B cell maturat
Autor:
Jesse D. Bloom, Elizabeth M Krantz, Carla S Walti, Caitlin R Wolf, Rebecca Gardner, Kiel Shuey, Jim Boonyaratanakornkit, Jacob Keane-Candib, Damian J. Green, Steven A. Pergam, Tillie Loeffelholz, Andrea N. Loes, Justin J. Taylor, Helen Y. Chu, Cameron J. Turtle, David G. Maloney, Joshua A. Hill, Andrew J. Cowan
Publikováno v:
Journal for Immunotherapy of Cancer
medRxiv
article-version (status) pre
article-version (number) 1
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
medRxiv
article-version (status) pre
article-version (number) 1
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Recipients of chimeric antigen receptor-modified T (CAR-T) cell therapies for B cell malignancies have profound and prolonged immunodeficiencies and are at risk for serious infections, including respiratory virus infections. Vaccination may be import
Autor:
Thomas R. Chauncey, William I. Bensinger, Oliver W. Press, Jeannine S. McCune, Ajay K. Gopal, Barry E. Storer, Jennifer E. Vaughn, David G. Maloney, Leona Holmberg, Mohamed L. Sorror, Rainer Storb, Solomon A. Graf
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:1582-1587
Autologous hematopoietic cell transplantation (HCT) is a treatment option for many patients diagnosed with lymphoma. The effects of patient-specific factors on outcomes after autologous HCT are not well characterized. Here, we studied a sequential co
Autor:
Boglarka Gyurkocza, Brenda M. Sandmaier, Thomas R. Chauncey, David G. Maloney, Barry E. Storer, Rainer Storb
Publikováno v:
Leuk Lymphoma
We analyzed outcomes of 126 patients with hematologic malignancies, who relapsed after first allogeneic hematopoietic cell transplantation (HCT) and received subsequent allografts. In 17 cases, the original donors were utilized, while in 109 cases di
Autor:
Veronika Bachanova, Kwang Woo Ahn, Cesar O. Freytes, Siddhartha Ganguly, Reinhold Munker, Patrick J. Stiff, Basem M. William, Amanda F. Cashen, Sonali M. Smith, Ginna G. Laport, Taiga Nishihori, Anna Sureda, Samantha Jaglowski, Prakash Satwani, Jeanette Carreras, David J. Inwards, David G. Maloney, Mehdi Hamadani, Linda J. Burns, Jonathon B. Cohen, Edward Agura, Philippe Armand, Nilanjan Ghosh, Robert Peter Gale, Anita D'Souza, Abraham S. Kanate, Hillard M. Lazarus, Tanya Siddiqi, Maxim Norkin, Leona Holmberg, Jacob M. Rowe, Alberto Mussetti, Mohamed A. Kharfan-Dabaja, Tim Prestidge, Adriana K. Malone, Baldeep Wirk, Gorgun Akpek, Mitchell S. Cairo
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:1605-1611
Assessment with 18F-fluorodeoxy glucose (FDG)–positron emission tomography (PET) before hematopoietic cell transplantation (HCT) for lymphoma may be prognostic for outcomes. Patients with chemotherapy-sensitive non–Hodgkin lymphoma (NHL) undergoi
Autor:
Ted Gooley, Jennifer E. Vaughn, Mohamed L. Sorror, Smita Bhatia, Michael A. Pulsipher, David G. Maloney, Brenda M. Sandmaier, Mary E.D. Flowers, Rainer Storb, Richard T. Maziarz
Publikováno v:
British Journal of Haematology. 171:411-416
Summary The Haematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) was designed as a predictor of non-relapse mortality after HCT. Chronic graft-versus-host disease (GVHD) contributes to mortality after HCT. Here, we investigated whether the
Autor:
Ulrike Bacher, David A. Rizzieri, H. Schouten, Y-B Chen, Hillard M. Lazarus, Linda J. Burns, Reinhold Munker, Tao Wang, Silvia Montoto, Veronika Bachanova, R. T. Kamble, Sonali M. Smith, Wael Saber, Robert Peter Gale, Bipin N. Savani, Claudio G. Brunstein, G. Akpek, Ginna G. Laport, David G. Maloney, Mahmoud Aljurf, Jack W. Hsu, John Gibson, Jeanette Carreras, Peter H. Wiernik, Baldeep Wirk, Luciano J. Costa, John R. Wingard, Karen K. Ballen, Mitchell S. Cairo
Publikováno v:
Bone Marrow Transplantation, 50(2), 197-203. Nature Publishing Group
Bone marrow transplantation
Bone marrow transplantation
Alternative donor transplantation is increasingly used for high-risk lymphoma patients. We analyzed 1593 transplant recipients (2000-2010) and compared transplant outcomes in recipients of 8/8 allele HLA-A, -B, -C and DRB1 matched unrelated donors (M
Autor:
David G. Maloney, Brenda M. Sandmaier, John M. Pagel, Scott A. Lanum, Mazyar Shadman, Rainer Storb, Sangeeta Hingorani
Publikováno v:
Leukemia & Lymphoma. 58:740-742
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment for a number of benign and malignant hematological disorders; however, it is also associated with treatm...
Autor:
Paul J. Martin, Richard T. Maziarz, Mohamed L. Sorror, Frederick R. Appelbaum, Rainer Storb, David G. Maloney, Brenda M. Sandmaier, Smita Bhatia, Ted Gooley, Michael A. Pulsipher, H. Joachim Deeg, Michael B. Maris, Chris Davis, Stephanie J. Lee
Publikováno v:
Blood. 124:287-295
Whether the hematopoietic cell transplantation comorbidity index (HCT-CI) can provide prognostic information about development of acute graft-versus-host disease (GVHD) and subsequent mortality is unknown. Five institutions contributed information on